Abstract:CRISPR-Cas are adaptable natural prokaryotic defense systems that act against invading viruses and plasmids. Among the six currently known major CRISPR-Cas types, the type VI CRISPR-Cas13 is the only one known to exclusively bind and cleave foreign RNA. Within the last couple of years, this system has been adapted to serve numerous, and sometimes not obvious, applications, including some that might be developed as effective molecular therapies. Indeed, Cas13 has been adapted to kill antibiotic-resistant bacteria. In a cell-free environment, Cas13 has been used in the development of highly specific, sensitive, multiplexing-capable, and field-adaptable detection tools. Importantly, Cas13 can be reprogrammed and applied to eukaryotes to either combat pathogenic RNA viruses or in the regulation of gene expression, facilitating the knockdown of mRNA, circular RNA, and noncoding RNA. Furthermore, Cas13 has been harnessed for in vivo RNA modifications including programmable regulation of alternative splicing, A-to-I and C to U editing, and m6A modifications. Finally, approaches allowing for the detection and characterization of RNA-interacting proteins have also been demonstrated. Here, we provide a comprehensive overview of the applications utilizing CRISPR-Cas13 that illustrate its versatility. We also discuss the most important limitations of the CRISPR-Cas13-based technologies, and controversies regarding them.This article is categorized under: RNA Methods > RNA Analyses in CellsRNA Processing > RNA Editing and ModificationRNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Programmable RNA base editing with photoactivatable CRISPR-Cas13

RNA editing with CRISPR-Cas13

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Programmable RNA base editing via targeted modifications

Progress of CRISPR-based programmable RNA manipulation and detection.

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Programmable RNA targeting with CRISPR-Cas13

Applications of the versatile CRISPR‐Cas13 RNA targeting system

Advances in CRISPR-Cas Systems for RNA Targeting, Tracking and Editing.

Programmable RNA N 6 -methyladenosine editing by CRISPR-Cas9 conjugates

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Development and application of CRISPR/Cas9 technologies in genomic editing.

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

Advances in CRISPR-Cas systems for RNA targeting, tracking and editing

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Photoactivatable RNA N 6 -Methyladenosine Editing with CRISPR-Cas13.

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing

Targeted Manipulation of M6a RNA Modification Through CRISPR-Cas-based Strategies.

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11